ERYN MCINTYRE: Open Payments
NPI 1093901753 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,119 in 210 payments from 20 companies in 2025. Trend: 2023 $3,102 · 2024 $3,800 · 2025 $3,119
Food & beverage: $3,107Education: $12
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $369 |
| Janssen Biotech, Inc. | 25 | $349 |
| ABBVIE INC. | 34 | $346 |
| Arcutis Biotherapeutics, Inc. | 18 | $284 |
| Regeneron Healthcare Solutions, Inc. | 21 | $282 |
| LEO Pharma Inc. | 14 | $218 |
| GENZYME CORPORATION | 15 | $218 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $212 |
| Galderma Laboratories, L.P. | 28 | $206 |
| Lilly USA, LLC | 7 | $177 |
Products named: DUPIXENT, Bimzelx, TREMFYA, Zoryve, ADBRY, SKYRIZI, NEMLUVIO, TALTZ.
Industry payments across TX — which companies pay providers there.
